{"id":"W2603167456","doi":"10.1182/blood.v128.22.1103.1103","title":"Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Vincristine; Internal medicine; Regimen; Prednisone; Maintenance therapy; International Prognostic Index; Surgery; Cyclophosphamide; Oncology; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007185745,0.0005523704,0.002030641,0.0003571797,0.0002492946,0.00138929,0.0007442452,0.0008133143,0.002941369],"category_scores_gemma":[0.006388221,0.0003094519,0.002417619,0.0007431722,0.0004365295,0.0008248948,0.0004942821,0.001966042,0.0005666413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007843011,"about_ca_system_score_gemma":0.0007349829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000658861,"about_ca_topic_score_gemma":0.001034311,"domain_scores_codex":[0.9969002,0.001910362,0.0002563551,0.0002934859,0.0004637092,0.0001759644],"domain_scores_gemma":[0.9904861,0.003644872,0.003843389,0.00066677,0.0007803817,0.0005785672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6439795,0.00388069,0.06330349,0.003328688,0.02375145,0.0001767302,0.0004089985,0.003020581,0.009370456,0.00037642,0.00987338,0.2385298],"study_design_scores_gemma":[0.2533608,0.1858367,0.4772034,0.0007999177,0.03608552,0.001265782,0.0002496654,0.005552749,0.006678937,0.001455865,0.03125987,0.0002509336],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9578307,0.02971851,0.001084582,0.000882827,0.0001461782,0.0004870227,0.004848433,0.0001183507,0.004883463],"genre_scores_gemma":[0.9879416,0.004104803,0.0007946152,0.001207627,0.0002127532,0.0004214025,0.004311956,0.00004359449,0.0009617615],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007185745,"threshold_uncertainty_score":0.03800231,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01163876746170718,"score_gpt":0.254441246680421,"score_spread":0.2428024792187138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}